Filing Details
- Accession Number:
- 0001209191-21-043205
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-25 07:58:07
- Reporting Period:
- 2021-06-24
- Accepted Time:
- 2021-06-25 07:58:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1693011 | Inozyme Pharma Inc. | INZY | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1579247 | Axel Bolte | C/O Inozyme Pharma, Inc. 321 Summer Street Suite 400 Boston MA 02210 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-06-24 | 66,788 | $0.98 | 257,613 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-06-24 | 66,788 | $0.00 | 190,825 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2021-06-24 | 66,788 | $0.00 | 66,788 | $0.98 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
100,480 | 2027-06-27 | No | 4 | M | Direct |
Footnotes
- Represents a transfer by Reporting Person to HBM Partners AG in satisfaction of Reporting Person's obligation pursuant to a prior agreement with Reporting Person's former employer.
- These options are fully vested.